Vern Davenport is a Partner at NovaQuest Capital Management and has over 35 years of executive experience in building and transforming healthcare technology and services companies. He is responsible for transaction origination and execution, portfolio company value creation initiatives, investment policy, and day-to-day management of the Private Equity business.
Before joining NovaQuest, Mr. Davenport was CEO and Board Member at Medfusion. He was instrumental in the carve-out of the company from Intuit and returning its core portal solution to a market leadership position. Operationally, he helped create a culture where the company was awarded “Best Places to Work” by the Triangle Business Journal.
Prior to Medfusion, Mr. Davenport was Chairman and CEO of Medquist, leader in transcription services before and after the privatization of the company. Mr. Davenport facilitated a transformation of the business through the acquisition of a speech technology company, rebranding the company M*Modal and leading take private process that resulted in the sale of the business to One Equity Partners.
Mr. Davenport’s previous experience also includes his time as President, Allscripts; CEO, Misys Healthcare; GM & EVP, Kodak Health Group (now Carestream Health) and executive leadership roles at Siemens and Shared Medical Systems. Mr. Davenport started his career at IBM where he spent 11 years in sales, sales leadership and executive management positions.
Mr. Davenport received an MBA from East Carolina University as well as a BSBA in Business. Mr. Davenport currently serves on the East Carolina Board of Trustees as well as the WakeMed Health and Hospitals Board.
©2016 CutisPharma, Inc.
FI℞ST® and the FI℞ST® logo are registered
trademarks of CutisPharma, Inc.